Status:
COMPLETED
SPECS: Safe Pediatric Euglycemia in Cardiac Surgery
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Heart Defects, Congenital
Hyperglycemia
Eligibility:
All Genders
Up to 36 years
Phase:
NA
Brief Summary
Critically ill children, including children undergoing heart surgery, commonly develop elevated blood glucose (also known as "blood sugar") levels during their illness, which can lead to poor health o...
Detailed Description
Children undergoing heart surgery are under significant bodily stress, which can lead to higher than normal or lower than normal blood glucose levels. A synthetic form of insulin, a naturally occurrin...
Eligibility Criteria
Inclusion
- Undergoing heart surgery with cardiopulmonary bypass
- Recovering in the Cardiac ICU
Exclusion
- Enrolled in another interventional clinical trial with related study outcomes
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
989 Patients enrolled
Trial Details
Trial ID
NCT00443599
Start Date
November 1 2006
End Date
January 1 2014
Last Update
July 25 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Boston
Boston, Massachusetts, United States, 02115
2
C.S. Mott Children's Hospital
Ann Arbor, Michigan, United States, 48109